Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Psychopharmacology|June 24, 2022
Abuse Potential of Lemborexant, a Dual Orexin Receptor Antagonist, Compared With Zolpidem and Suvorexant in Recreational Sedative UsersIshani Landry, Nancy Hall, Jagadeesh Aluri, et al.Journal of Clinical Psychopharmacology|June 24, 2022
Acute Cognitive Effects of the Dual Orexin Receptor Antagonist Lemborexant Compared With Suvorexant and Zolpidem in Recreational Sedative UsersIshani Landry, Nancy Hall, Jagadeesh Alur, et al.The Lancet. Oncology|July 5, 2008
Smokeless tobacco and cancerPaolo Boffetta, Stephen Hecht, Nigel Gray, et al.Journal of Dual Diagnosis|December 28, 2023
Prevalence, Characteristics, and Reasons for Kratom Use among Psychiatrically Ill Inpatients Who Use SubstancesCornel N Stanciu, Saeed Ahmed, Zouina Sarfraz, et al.Pain Medicine (Malden, Mass.)|March 25, 2017
Human Abuse Potential of the New Opioid Analgesic Molecule NKTR-181 Compared with OxycodoneLynn Webster, Jack Henningfield, August R Buchhalter, et al.Scientific Reports|July 6, 2022
REL-1017 (esmethadone; D-methadone) does not cause reinforcing effect, physical dependence and withdrawal signs in Sprague Dawley ratsJack Henningfield, David Gauvin, Francesco Bifari, et al.BMJ Global Health|March 24, 2023
Surgery for rheumatic heart disease in the Northern Territory, Australia, 1997-2016: what have we gained?James Doran, David Canty, Karen Dempsey, et al.Pageof 2